268 related articles for article (PubMed ID: 26891703)
21. Fully-automated sarcopenia assessment in head and neck cancer: development and external validation of a deep learning pipeline.
Ye Z; Saraf A; Ravipati Y; Hoebers F; Zha Y; Zapaishchykova A; Likitlersuang J; Tishler RB; Schoenfeld JD; Margalit DN; Haddad RI; Mak RH; Naser M; Wahid KA; Sahlsten J; Jaskari J; Kaski K; Mäkitie AA; Fuller CD; Aerts HJWL; Kann BH
medRxiv; 2023 Mar; ():. PubMed ID: 36945519
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.
Bøje CR; Dalton SO; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
Radiother Oncol; 2014 Jan; 110(1):91-7. PubMed ID: 24412015
[TBL] [Abstract][Full Text] [Related]
23. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.
Lee WR; Berkey B; Marcial V; Fu KK; Cooper JS; Vikram B; Coia LR; Rotman M; Ortiz H
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1069-75. PubMed ID: 9869231
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
[TBL] [Abstract][Full Text] [Related]
25. Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment.
Ahern E; Brown TE; Campbell L; Hughes BGM; Banks M; Lin CY; Kenny LM; Bauer J
Br J Nutr; 2023 Feb; 129(3):406-415. PubMed ID: 35152926
[TBL] [Abstract][Full Text] [Related]
26. Racial parities in outcomes after radiotherapy for head and neck cancer.
Liu GF; Ranck MC; Solanki AA; Cao H; Kolokythas A; Wenig BL; Chen L; Ard S; Weichselbaum RR; Halpern H; Spiotto MT
Cancer; 2014 Jan; 120(2):244-52. PubMed ID: 24122486
[TBL] [Abstract][Full Text] [Related]
27. Biomechanical imaging biomarker during chemoradiotherapy predicts treatment response in head and neck squamous cell carcinoma.
Fujimoto K; Shiinoki T; Kawazoe Y; Yuasa Y; Mukaidani W; Manabe Y; Kajima M; Tanaka H
Phys Med Biol; 2024 Feb; 69(5):. PubMed ID: 38359451
[No Abstract] [Full Text] [Related]
28. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
[TBL] [Abstract][Full Text] [Related]
29. Can radiological changes in lymph node volume during treatment predict success of radiation therapy in patients with locally advanced head and neck squamous cell carcinoma?
Mishra S; Hammond A; Read N; Venkatesan V; Winquist E; Nichols A; Warner A; Palma D
J Med Imaging Radiat Oncol; 2013 Oct; 57(5):603-9. PubMed ID: 24119277
[TBL] [Abstract][Full Text] [Related]
30. Weight and body mass index in relation to irradiated volume and to overall survival in patients with oropharyngeal cancer: a retrospective cohort study.
Ottosson S; Söderström K; Kjellén E; Nilsson P; Zackrisson B; Laurell G
Radiat Oncol; 2014 Jul; 9():160. PubMed ID: 25052587
[TBL] [Abstract][Full Text] [Related]
31. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
[TBL] [Abstract][Full Text] [Related]
32. The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma.
Zhang I; Branstetter BF; Beswick DM; Maxwell JH; Gooding WE; Ferris RL
Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1106-11. PubMed ID: 22106234
[TBL] [Abstract][Full Text] [Related]
33. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
[TBL] [Abstract][Full Text] [Related]
34.
Kim SA; Roh JL; Kim JS; Lee JH; Lee SH; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2017 Feb; 72():62-70. PubMed ID: 28027517
[TBL] [Abstract][Full Text] [Related]
35. Health-related quality of life before and after head and neck squamous cell carcinoma: Analysis of the Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.
Rettig EM; D'Souza G; Thompson CB; Koch WM; Eisele DW; Fakhry C
Cancer; 2016 Jun; 122(12):1861-70. PubMed ID: 27182694
[TBL] [Abstract][Full Text] [Related]
36. Impact of pretreatment body mass index on patients with head-and-neck cancer treated with radiation.
Pai PC; Chuang CC; Tseng CK; Tsang NM; Chang KP; Yen TC; Liao CT; Hong JH; Chang JT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e93-e100. PubMed ID: 22342298
[TBL] [Abstract][Full Text] [Related]
37. Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary?
Fried D; Lawrence M; Khandani AH; Rosenman J; Cullip T; Chera BS
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):748-54. PubMed ID: 22414285
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas.
Levy A; Blanchard P; Bellefqih S; Brahimi N; Guigay J; Janot F; Temam S; Daly-Schveitzer N; Bourhis J; Tao Y
Anticancer Drugs; 2014 Nov; 25(10):1220-6. PubMed ID: 25144345
[TBL] [Abstract][Full Text] [Related]
39. Disease-induced and treatment-induced alterations in body composition in locally advanced head and neck squamous cell carcinoma.
Willemsen ACH; Hoeben A; Lalisang RI; Van Helvoort A; Wesseling FWR; Hoebers F; Baijens LWJ; Schols AMWJ
J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):145-159. PubMed ID: 31536685
[TBL] [Abstract][Full Text] [Related]
40. Body composition changes in patients with head and neck cancer under active treatment: a scoping review.
Ferrão B; Neves PM; Santos T; Capelas ML; Mäkitie A; Ravasco P
Support Care Cancer; 2020 Oct; 28(10):4613-4625. PubMed ID: 32533436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
